The effects of age on uptake, serum half-life and bioavailability of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, in male C57BL/6J mice

Regulatory Peptides

Volumn 150, Issue 1-3, 2008, Pages 62-65

  Lee, Daniel W ^a   Leinung, Matthew C ^a   Grasso, Patricia ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Energy balance; Leptin; Pharmacokinetics; Synthetic peptides

Indexed keywords

AMIDE; LEPTIN; LEUCINE;

ANIMAL EXPERIMENT; ARTICLE; ASSAY; BIOAVAILABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GROUPS BY AGE; MALE; MOUSE; NONHUMAN; PLASMA HALF LIFE; PRIORITY JOURNAL;

AGING; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BODY WEIGHT; ENZYME-LINKED IMMUNOSORBENT ASSAY; HALF-LIFE; INJECTIONS, INTRAPERITONEAL; LEPTIN; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; STEREOISOMERISM;

MUS;

EID: 51249102752     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.03.008     Document Type: Article

References (20)

1. Grasso P., Leinung M.C., Ingher S.P., and Lee D.W. In vivo effects of leptin-related synthetic peptides on body weight and food intake in female ob/ob mice: localization of leptin activity to domains between amino acid residues 106-140. Endocrinology 138 (1997) 1413-1418
2. Grasso P., Leining M.C., and Lee D.W. Epitope mapping of secreted mouse leptin utilizing peripherally administered synthetic peptides. Regul Pept 85 (1999) 93-100
3. Grasso P., White D.W., Tartaglia L.A., Leinung M.C., and Lee D.W. The effects of leptin-related synthetic peptide116-130 on food intake and body weight gain in female C57BL/6J ob/ob mice are not mediated by peptide activation of the long isoform of the leptin receptor. Diabetes 48 (1999) 2204-2209
4. Rozhavskaya-Arena M., Lee D.W., Leinung M.C., and Grasso P. Design of a synthetic leptin agonist: effects on energy balance, glucose homeostasis and thermoregulation. Endocrinology 141 (2000) 2501-2507
5. Grasso P., Rozhavskaya-Arena M., Leinung M.C., and Lee D.W. [D-Leu-4]OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6J ob/ob mice. Regul Pept 101 (2001) 123-129
6. 116-130 stimulates prolactin and luteinizing hormone secretion in fasted adult male rats. Neuroendocrinology 70 (1999) 213-220
7. Malendowicaz L.K., Neri G., Jedzejczak N., Nussdorfer G.G., and Hocho A. Leptin (116-130) enhances the proliferative activity of immature rat adrenal cortex. Med Sci Res 27 (1999) 675-676
8. Tena-Sempere M., Pinilla L., Gonzalez L.C., Navarro J., Dieguez C., Casaneuva F.F., et al. In vivo pituitary and testicular effects of the leptin-related synthetic peptide (116-130) amide involve actions both similar to and distinct from those of the native leptin molecule in the adult rat. Eur J Endocrinol 142 (2000) 406-410
9. Malendowicz L.K., Neri G., Jedzejczak N., Hochol A., and Nussdorfer G.G. Effects of recombinant murine leptin [1-147] and leptin fragment 116-130 on steroid secretion and proliferative activity of the regenerating rat adrenal cortex. Endocr Res 26 (2000) 109-118
10. Malendowicz L.K., Neri G., Markowska A., Hochol, Nussdorfer G.G., and Majchrzak M. Effects of leptin and leptin fragments on steroid secretion of freshly dispersed rat adrenocortical cells. J Steroid Biochem Mol Biol 87 (2003) 265-268
11. Markowska A., Neri G., Hochol A., Nowak M., Nussdorfer G.G., and Malendowicz L.K. Effects of leptin and leptin fragments on steroid secretion and proliferative activity of regenerating rat adrenal cortex. Int J Mol Med 13 (2004) 139-141
12. Malendowicz L.K., Spinazzi R., Tortorella C., Nussdorfer G.G., Ziolkowska A., and Rucinski M. Effects of leptin and leptin fragments on corticosterone secretion and growth of cultured rat adrenocortical cells. Int J Mol Med 14 (2004) 873-877
13. Oliveira Jr. V.X., Fazio M.A., Miranda M.T., daSilva J.M., Bittencourt J.C., Elias D.F., and Miranda A. Leptin fragments induce Fos immunoreactivity in rat hypothalamus. Regul Pept 127 (2005) 123-132
14. Lonnqvist F., Arner P., Nordfors L., and Shaling M. Overexpression of the obese (ob) gene in adipose of human obese subjects. Nat Med 1 (1995) 950-953
15. Reed D.R., Ding Y., Xu W., Cather C., Green E.D., and Price R.A. Extreme obesity may be linked to markers flanking the human OB gene. Diabetes 45 (1996) 691-694
16. Oksanen L., Kaprio J., Mustajoki P., and Kontula K. A common pentanucleotide polymorphism of the 3′-untranslated part of the leptin receptor generates a putative stem-loop motif in the mRNA and is associated with serum insulin levels in obese individuals. Int J Obes Relat Metab Disord 22 (1998) 634-640
17. Zimanyl I.A., and Poindexter G.S. NPY-ergic agonists for the treatment of obesity. Drug Dev Res 51 (2000) 91-111
18. Silva J.E. Uncoupling proteins 2 and 3 and their potential role in human obesity. Drug Dev Res 51 (2000) 112-123
19. Spiegelman B.M., and Flier J.S. Obesity and the regulation of energy balance. Cell 104 (2001) 513-543
20. Walder K., and deSilva A. Leptin and the treatment of obesity. Drug Dev Res 51 (2000) 66-79